Product Information:
| Cat. No.: EX-A5150 | Purity: >98% |
![]() | |
| Chemical structure of Doxorubicin-MVCP |
| Size | Unit Price (US$) | Stock | Quantity | Order |
|---|
| Send PO to E-mail:[email protected]; or Fax:+86 020 81619670 |
| Discount Request |
| Synonyms | MC-Val-Cit-PAB-Doxorubicin |
|---|---|
| Synonyms 2 | MC-Val-Cit-PAB-Dox |
| Purity | >98% |
| Formula | C56H67N7O19 |
| Mol Weight | 1142.1667 |
| State | solid powder |
| Solubility | Soluble in DMSO |
| Shelf Life | >2 years if stored properly |
| Storage | Powder -20℃ 2 years; In solvent -20℃ 1 month; |
| Shipping | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Reference: | [1]. Wu DC, et al. Preparation, drug release, and cell growth inhibition of a gelatin: doxorubicin conjugate. Pharm Res. 2013 Aug;30(8):2087-96. PMID: 23686374.
[2]. She W, et al. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials. 2013 Mar;34(9):2252-64. PMID: 23298778. [3]. Schoener CA, et al. An inulin and doxorubicin conjugate for improving cancer therapy. J Drug Deliv Sci Technol. 2013;23(2):111-118. PubMed PMID: 24734120; PubMed Central PMCID: PMC3984582. [4]. Ye WL, et al. Synthesis of a new pH-sensitive folate-doxorubicin conjugate and its antitumor activity in vitro. J Pharm Sci. 2013 Feb;102(2):530-40. PMID: 23169439. [5]. Huan M, et al. In vivo anti-tumor activity of a new doxorubicin conjugate via α-linolenic acid. Biosci Biotechnol Biochem. 2012;76(8):1577-9. Epub 2012 Aug 7. PubMed PMID: 22878199. |
| CoA | CoA of Doxorubicin-MVCP |
KEYWORDS: buy Doxorubicin-MVCP | Doxorubicin-MVCP supplier | purchase | cost | manufacturer | order | distributor | buy | supplier


Inhibitor Specialist 
